A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
about
Options for temporary mechanical circulatory supportTemporary mechanical circulatory support: a review of the options, indications, and outcomesTrends in the use of percutaneous ventricular assist devices: analysis of national inpatient sample data, 2007 through 2012.A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention.Use of left ventricular support devices during acute coronary syndrome and percutaneous coronary intervention.The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella RegistryMassive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMOPercutaneous Ventricular Assist Devices and ECMO in the Management of Acute Decompensated Heart Failure.Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella CathetersThe contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience.Use of a Vascular Sheath in the Axillary Artery as an Alternative Access Approach for Placing an Impella 5.0 Device.Use of Mechanical Circulatory Support in Percutaneous Coronary Intervention in the United States.Percutaneous left ventricular assist device in high risk percutaneous coronary intervention.Total Mechanical Unloading Minimizes Metabolic Demand of Left Ventricle and Dramatically Reduces Infarct Size in Myocardial InfarctionThe reversal of cardiology practices: interventions that were tried in vainAggressive plaque modification with rotational atherectomy and cutting balloon for optimal stent expansion in calcified lesions.Effect of percutaneous ventricular assist devices on renal function.Defining the role for percutaneous mechanical circulatory support devices for medically refractory heart failure.Health economics of percutaneous hemodynamic support in the treatment of high-risk cardiac patients: a systematic appraisal of the literature.ST elevation myocardial infarction: recent advances and updates.Transplantation in end-stage pulmonary hypertension (Third International Right Heart Failure Summit, part 3).Percutaneous Hemodynamic Support in PCI.The evolution of temporary percutaneous mechanical circulatory support devices: a review of the options and evidence in cardiogenic shock.Interventional Management of Unprotected Left Main Coronary Artery Disease: Patient Selection and Technique Optimization.Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm.Revascularization in Severe Left Ventricular Dysfunction: Does Myocardial Viability Even Matter?Hemodynamic Support Devices for Shock and High-Risk PCI: When and Which One.Advances in temporary mechanical support for treatment of cardiogenic shock.Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: An analysis of the Medicare database.Mechanical Circulatory Support for Decompensated Heart Failure.A retrospective analysis of Impella use in all-comers: 1-year outcomes.Unprotected Left Main Disease: Indications and Optimal Strategies for Percutaneous Intervention.Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization.Percutaneous mechanical circulatory support: current concepts and future directions.The Role for Cardiovascular Remodeling in Cardiovascular Outcomes.An updated review of cardiac devices in heart failure.Novel percutaneous mechanical circulatory support devices and their expanding applications.The Impella® Recover mechanical assist device in acute cardiogenic shock: a single-centre experience of 66 patients.Caring for critically ill oldest old patients: a clinical review.Preoperative intra-aortic balloon pump use in high-risk patients prior to coronary artery bypass graft surgery decreases the risk for morbidity and mortality-A meta-analysis of 9,212 patients.
P2860
Q26770310-D2572A4D-AA08-49F0-8F46-197AC0D7C4BCQ26824537-34BD8102-A712-40F1-82FE-712D4C101343Q30919406-8DE0881D-B89C-41EA-9419-C21EE5F8DED2Q33652803-0C5B5FB5-4F6C-419E-929E-06C3437B3993Q34444090-9CEEF0F0-139A-44A2-8B76-AACCB0F1F23FQ34548705-6AE22FD0-2E85-4382-8265-6EE64B878828Q35210117-EC265961-3737-4477-B940-AC3B43B0F773Q35545474-8184540B-E46F-4C3B-A74C-AF115FFC70A3Q35756621-56B2914D-05B7-4D10-816B-0D94CA3BF4D3Q35807196-E3C993CB-940A-431D-ADF0-30ADC428EEB0Q36052039-1EAE4EEA-3518-4126-BACA-97D6CE1800B8Q36403148-A6DEF1EA-2605-46FB-93F2-EA96484DB245Q36724085-180CCCD1-3C75-445E-94D8-BD7BDADE13E1Q36848829-1EEC8145-DF60-46B0-AD58-10521329E243Q37425564-02A0BC59-0CB5-43C1-9CE5-50B51F386292Q37701916-7506FBB8-299C-4789-B387-8512719EFECDQ38076225-9AB519B2-C831-41E0-B0EF-4099C6CB4CAAQ38079766-CF91E512-1018-4416-9CA5-3E2F37EB73E6Q38204771-C4FD2B5C-1EB3-4FB2-9134-7033CE5151AEQ38263602-D3009548-43CC-4CE3-8B12-70A4D7E0A09FQ38327928-263FA420-2EC8-42A9-A5A7-1D6D9F53988DQ38418516-E27BD7DB-ECBA-4DB5-B71F-EDDDB2E1AFFCQ38433822-D1A9DC46-F758-41F6-A538-C3ABCE9B84FDQ38528371-6E3DA258-BB70-4A83-A2F6-3B0066AA0D84Q38539605-FBE594C8-390F-44F0-824E-F1462B75D00FQ38544269-6961AB77-751D-4A6D-A9CF-D4A2D12403F5Q38601021-AC5C9494-FBC9-488F-B611-852CA4762C5BQ38628381-07358633-F472-4E98-9A8E-FAEC3BDF5CCFQ38628892-1CB07E0C-1575-4579-B4EB-0243E542B821Q38648838-F36BB368-3AF4-4266-AD2B-CA5464CB2EDBQ38665435-76B6805C-97F6-4480-8113-7E765EC6D1F6Q38732511-8C7C377D-6868-4CD1-8599-0F9D803B51E0Q38779868-9374ECF2-8FE0-4A3D-9838-175B4118B384Q38833101-8401622C-F93A-4446-8779-7E4996E02CFAQ38867740-95AF12DF-25F9-4E78-BD6C-9F1DB94CC69AQ38876024-8CF2CA32-1142-4C2B-BEC9-8157AC3A52C0Q38906507-A213CB2A-B4B2-4E4D-8BD6-4E97459D22C1Q38921323-B1921B7D-6EC3-404A-ACF7-321491A20DF7Q38985805-BE36E43E-3EC3-4C07-AC3A-99CBBCD13BDEQ39155829-874DD288-FE04-43E4-B34A-7760C18C2B15
P2860
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A prospective, randomized clin ...... vention: the PROTECT II study.
@en
type
label
A prospective, randomized clin ...... vention: the PROTECT II study.
@en
prefLabel
A prospective, randomized clin ...... vention: the PROTECT II study.
@en
P2093
P50
P1433
P1476
A prospective, randomized clin ...... vention: the PROTECT II study.
@en
P2093
Brijeshwar Maini
Igor Palacios
Jeffrey Moses
Jose P S Henriques
Magnus Ohman
Neal S Kleiman
Simon Dixon
Suresh Mulukutla
Vladimír Dzavík
William W O'Neill
P304
P356
10.1161/CIRCULATIONAHA.112.098194
P407
P577
2012-08-30T00:00:00Z